PAIN
Volume 139, Issue 2 , Pages 477-479, 15 October 2008

Response to: Long-term trials of pregabalin and duloxetine for fibromyalgia symptoms: How study designs can affect placebo factors

Nuffield Department of Anaesthetics, University of Oxford, Level 6, West Wing, John Radcliffe Hospital, Oxford OX3 9DU, UK

Received 18 June 2008; accepted 28 July 2008. published online 15 September 2008.

No abstract is available. To read the body of this article, please view the Full Text online.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0304-3959(08)00423-5

doi:10.1016/j.pain.2008.07.026

Refers to article:

  • Role of placebo factors in clinical trials with special focus on enrichment designs , 15 September 2008

    Roland Staud, Donald D. Price
    PAIN 15 October 2008 (Vol. 139, Issue 2, Pages 479-480)

PAIN
Volume 139, Issue 2 , Pages 477-479, 15 October 2008

Article Tools